Animal spirits awaken in the biotech sector

Viralytics (VLA) $1.68

Viralytics chief Malcolm McColl recently told a biotech forum that after a quiet 2017 for global takeover activity in the pharmaceutical sector, Trump’s tax cuts would fire up activity this year.

That’s because corporates will have more money in their tills to play with, while the tax reforms also make it easier to repatriate cash to the US.

Read more...

A boring stock that can make you exciting money

K2Fly (K2F) 25c

Is that the time?

Partygoers tend to suddenly remember the babysitter or an early morning appointment when the conversation turns to consulting systems integration for infrastructure and asset-heavy industries.

But for K2fly investors sitting on a 300 per cent gain over the last two months, these topics are even more riveting than house prices and whether Bernard Tomic is simply a twat or a lost soul deserving of sympathy.

Read more...

When systems integration becomes a compelling party topic

THE NEW CRITERION

K2Fly (K2F) 32c

Is that the time?

Partygoers suddenly remember the babysitter or an early morning appointment when the conversation turns to consulting systems integration for infrastructure and asset-heavy industries.

But for K2fly investors sitting on a 300 per cent-plusgain over the last two months, this party topic is more riveting than house prices and whether Bernard Tomic is simply a twat or a lost soul deserving of sympathy.

Read more...

The home grown sleeper that became a $2 billion a year global giant

 RESMED

By TIM BOREHAM

ASX: RMD (Chess depository interests); New York Stock Exchange: RMD

Share price: $12.48; Market cap: $17.82 billion

Shares on issue: 142,891,971 US shares; 1,428,919,708 CDIs*

Financials (December half): revenue $US1,125 billion ($A1,409 billion) (up 13%), operating income $US258.5 million (up 35%), net income $US95,651,000 ($A119,792,200) (down 37%).

Read more...

From disposable nappies to stem cells: how Cynata got out of the poo

Posted on Feb 10 2018

 CYNATA THERAPEUTICS

ASX CODE: CYP

SHARE PRICE: 81c

SHARES ON ISSUE: 90.06m

MARKET CAP: $73m

CEO: Dr Ross Macdonald

BOARD: Dr Paul Wotton (chairman), Ross Macdonald, Dr Stewart Washer, Dr John Chiplin, Peter Webse

 FINANCIALS (December quarter) revenue nil, cash generated $145,000, cash balance $8.839mm*, estimated December quarter cash burn $1.753m

Read more...

Nickel: the real battery metal?

 Panoramic Resources (PAN) 42c

In a potent sign that the long-subdued nickel market is finally turning, the WA nickel stalwart is poised to press the button to restart its dormant mainstay mine after investors flocked to its recent capital raising.

The mine, Savannah in the east Kimberley, was placed on care and maintenance in mid 2016 after becoming victim to the plunging price for the stainless steel ingredient.

Read more...